Moderna COVID-19 Vaccine (2023-2024 Formula)
is authorized for use in children
6 months through 11 years of age.
Vaccine authorization
Moderna COVID-19 Vaccine (2023-2024 Formula) is authorized for use in eligible individuals 6 months through 11 years of age. For more information about the dosing schedule, please see the Vaccine Fact Sheet for Healthcare Providers and the Vaccine Fact Sheet for Recipients.
Dosing updates
Dosing Updates for Individuals With Certain Kinds of Immunocompromise Individuals 6 months through 11 years of age with certain kinds of immunocompromise‡ should complete at least a three-dose series with a COVID-19 vaccine, each dose one month apart.¶ At least 1 dose should be with a COVID-19 vaccine (2023-2024 formula).
If previously not vaccinated, complete the three-dose series with Moderna COVID-19 Vaccine (2023-2024 Formula).
If previously vaccinated with one or two dose(s) of Moderna COVID-19 Vaccine (Original monovalent) and/or the Moderna COVID-19 Vaccine, Bivalent, complete the remaining dose(s) in the three-dose series with Moderna COVID-19 Vaccine (2023-2024 Formula).
If previously vaccinated with three or more doses, administer a single dose of Moderna COVID-19 Vaccine (2023-2024 Formula) at least two months following the last previous dose.#**
An additional dose of Moderna COVID-19 Vaccine (2023-2024 Formula) may be administered at least 2 months following the last dose of a COVID-19 vaccine (2023-2024 formula).††‡‡ Additional doses of Moderna COVID-19 Vaccine (2023-2024 Formula) may be administered at the discretion of the healthcare provider, taking into consideration the individual’s clinical circumstances. The timing of the additional doses may be based on the individual’s clinical circumstances.
Dosage amount updates
For individuals 6 months through 11 years of age, a single dose of Moderna COVID-19 Vaccine (2023-2024 Formula) is 0.25 mL regardless of age and number of vaccines previously received.
Contact us
The Moderna Call Center is available from: 8 AM to 8 PM ET, Monday through Friday, at 1-866-MODERNA (1-866-663-3762)
* Previous dose(s) of Moderna COVID-19 vaccine(s) refers to Moderna COVID-19 Vaccine (Original monovalent) and Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5). These vaccines are no longer authorized for use in the United States.
† Not previously vaccinated with any COVID-19 vaccine.
‡ Individuals with certain kinds of immunocompromise 6 months through 11 years of age should complete at least a 3-dose series with a COVID-19 vaccine, each dose 1 month apart. At least 1 dose should be with a COVID-19 vaccine (2023-2024 formula). “Certain kinds of immunocompromise” refers to individuals who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
§ Individuals turning from 4 years to 5 years of age during the vaccination series should receive both doses with Moderna COVID-19 Vaccine (2023-2024 Formula).
|| COVID-19 vaccine refers to the monovalent COVID-19 vaccines that encode the spike protein of the original SARS-CoV-2 and the bivalent COVID-19 vaccines encoding the spike protein of original SARS-CoV-2 and of the Omicron variant lineages BA.4 and BA.5 that are no longer authorized for use in the United States.
¶ COVID-19 vaccine, each dose of the 3-doses series given one month apart, refers to Moderna COVID-19 vaccines. Individuals turning from 11 to 12 years of age during the vaccination series may complete the series with doses of Moderna COVID-19 Vaccine (2023-2024 Formula).
# For immunocompromised individuals 6 months through 4 years of age, the last previous dose refers to the last dose of Moderna COVID-19 Vaccine (Original monovalent) or Moderna COVID-19 Vaccine, Bivalent which are no longer authorized for use in the U.S.
** For immunocompromised individuals 5 years through 11 years of age, the last previous dose refers to the last dose of a COVID-19 vaccine (original monovalent) or bivalent COVID-19 vaccine which are no longer authorized for use in the U.S.
†† For immunocompromised individuals 6 months through 4 years of age, the last dose of a COVID-19 vaccine (2023-2024 formula) refers to a dose with Moderna COVID-19 Vaccine (2023-2024 Formula).
‡‡ For immunocompromised individuals 5 years through 11 years of age, the last dose of a COVID-19 vaccine (2023-2024 formula) refers to a dose with Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) or Moderna COVID-19 Vaccine (2023-2024 Formula).
Use Moderna Direct—our online ordering platform—to get Moderna COVID-19 Vaccine (2023-2024 Formula) for your practice. Continue to Moderna Direct